Literature DB >> 20633794

Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma.

Brandi M Kenner-Bell, Amy S Paller, Mario E Lacouture.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20633794     DOI： 10.1016/j.jaad.2009.10.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  A hypomorphic Egfr allele does not ameliorate the palmoplantar keratoderma caused by SLURP1 deficiency.

Authors:  Christopher M Allan; Deanna Tran; Yiping Tu; Patrick J Heizer; Lorraine C Young; Loren G Fong; Anne P Beigneux; Stephen G Young
Journal:  Exp Dermatol       Date:  2017-07-27       Impact factor: 3.960

2.  Olmutinib-induced palmoplantar keratoderma.

Authors:  K L Chen; Y T Cho; C W Yang; Y S Sheen; C W Liang; M E Lacouture; C Y Chu
Journal:  Br J Dermatol       Date:  2017-12-18       Impact factor: 9.302

Review 3.  Diagnosis and Management of Inherited Palmoplantar Keratodermas.

Authors:  Bjorn R Thomas; Edel A O'Toole
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.